• Human APIs PowderRespiratory Drugs Raw Material Antiviral Antibacterial Antipyretic Analgesics Antihistamine Drugs Antineoplastic Urinary System Drugs Endocrine System Other
  • Pharmaceutical IntermediatesPharmaceutical intermediates Heterocyclic Compound OLED material intermediate Diphenylamine intermediates Nutritional Supplements Pharmaceutical raw materials
  • Medicine ExcipientsFiller Solubilizers Coating material Disintegrant Excipient Iubricant Other
  • Veterinary raw materialsAntibacterial anti-inflammatory Respiratory Drugs Gastrointestinal Drugs Disinfectant Anthelmintics Antiviral drugs Sow health care Feed additives
  • About UsCompany profileQualificationQuality AssuranceService teamFactory TourR&D Center
  • Veterinary Medicine Ciprofloxacin Lactate Powder CAS 97867-33-9 Raw Materials

    • Veterinary Medicine Ciprofloxacin Lactate Powder CAS 97867-33-9 Raw Materials
    • Veterinary Medicine Ciprofloxacin Lactate Powder CAS 97867-33-9 Raw Materials
    • Veterinary Medicine Ciprofloxacin Lactate Powder CAS 97867-33-9 Raw Materials storehouse
    • Veterinary Medicine Ciprofloxacin Lactate Powder CAS 97867-33-9 Raw Materials quality testing
    • Veterinary Medicine Ciprofloxacin Lactate Powder CAS 97867-33-9 Raw Materials quality testing
    • Veterinary Medicine Ciprofloxacin Lactate Powder CAS 97867-33-9 Raw Materials certificate

    Product Overview:

    Ciprofloxacin Lactate is a third-generation quinolone antibacterial drug, its main mechanism of action is to inhibit the DNA gyrase involved in nucleic acid synthesis, and prevent cell division by destroying the structure of bacterial DNA, and then kill bacteria.Ciprofloxacin Lactate is a third-generation synthesized quinolone, with a wide spectrum of antimicrobial properties, and strong action. Bacteria highly sensitive to Ciprofloxacin Lactate Raw Materials include gonococcus, staphylococcus aureus, streptococcus, E. coli and so on. Haemophilus ducreyi is also very sensitive to this product.

    Veterinary Medicine Ciprofloxacin Lactate Powder CAS 97867-33-9 Raw Materials Attributes

    Veterinary Medicine Ciprofloxacin Lactate Powder CAS 97867-33-9 Raw Materials

    CAS: 97867-33-9

    MF: C20H24FN3O6

    Ciprofloxacin Lactate

    MW: 421.43

    EINECS:1806241-263-5

    Specification​: 99% min Ciprofloxacin Lactate

    Sample: Ciprofloxacin Lactate Powder

    Packaging:1kg/bag, 25kg/drum

    Brand: Henrikang

    Appearance: White Powder

    Storage: Cool Dry Place

    Shelf Life: 2 Years

    Test Method: HPLC

    Portal:https://henrikang.en.made-in-china.com/

    Veterinary Medicine Ciprofloxacin Lactate Powder CAS 97867-33-9 Raw Materials Details

    Ciprofloxacin Lactate Powder Usage and Synthesis.

    Ciprofloxacin Lactate is a third-generation quinolone antibacterial drug, its main mechanism of action is to inhibit the DNA gyrase involved in nucleic acid synthesis, and prevent cell division by destroying the structure of bacterial DNA, and then kill bacteria. Its main mechanism of action is to inhibit the DNA gyrase involved in nucleic acid synthesis, and prevent cell division by destroying the structure of bacterial DNA, and then kill bacteria.

    Ciprofloxacin Lactate Powder

    Ciprofloxacin Lactate is a third-generation synthesized quinolone, with a wide spectrum of antimicrobial properties, and strong action. highly sensitive to Ciprofloxacin Lactate Raw Materials include gonococcus, staphylococcus aureus, streptococcus, E. coli and so on. Haemophilus ducreyi is also very sensitive to Ciprofloxacin Lactate. Haemophilus ducreyi is also very sensitive to this product.

    Uses and functions of Ciprofloxacin Lactate Powder.

    Ciprofloxacin Lactate is a quinolone with broad-spectrum antimicrobial activity. It acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication and leading to bacterial death.

    Its antimicrobial activity is the strongest among the widely used fluoroquinolones, characterized by strong antimicrobial ability, low antimicrobial concentration, low toxicity and side effects, and bacteria are not easy to develop resistance to it,

    Ciprofloxacin Lactate Powder

    and it has a strong killing effect on Gram-negative and part of Gram-positive bacteria, such as E. coli, dysentery bacillus, Aspergillus spp, Pseudomonas aeruginosa, pulmonary diplococcus, and staphylococcus.

     

    Pharmacological Effects of Ciprofloxacin Lactate Powder.

    Ciprofloxacin Lactate Powder is a third-generation synthetic quinolone with wide antibacterial spectrum and strong effect. Bacteria highly sensitive to this product include gonococcus, staphylococcus aureus, streptococcus, E. coli and so on. Haemophilus ducreyi is also very sensitive to this product. It is the first broad-spectrum antimicrobial agent for the treatment of Pseudomonas aeruginosa infections by oral administration. It is weak against Chlamydia trachomatis and Mycoplasma solani and largely ineffective against Spirochetes syphilis. Tablets are effective when taken orally on an empty stomach.

    • 1. Genitourinary infections include simple or complicated urinary tract infections, bacterial prostatitis, gonococcal urethritis, pyelonephritis, cervicitis (including those caused by enzyme-producing strains).
    • 2. Respiratory infections include tonsillitis, pharyngitis, acute bronchitis and lung infections.
    • 3. Infections of the digestive system, including gastrointestinal infections, cholecystitis, perianal abscesses, etc.
    • 4. Infections of the organs, including conjunctivitis, sinusitis, otitis media, etc. 5. Others can be used for bone and joint infections, skin and soft tissue infections and blood-borne infections.
    Ciprofloxacin Lactate Powder

    Production method of Ciprofloxacin Lactate Powder.

    • It is a new quinolone broad-spectrum antibacterial drug with strong effect on Gram-positive and negative bacteria. The antibacterial spectrum of this product is similar to that of haloperidol. It has strong antibacterial activity against Gram-positive bacteria, strong antibacterial activity against Gram-negative bacteria, and strong antibacterial activity against Pseudomonas aeruginosa and anaerobes.
    • Used for systemic infections caused by sensitive bacteria and mycoplasma (mycoplasma) infections use new broad-spectrum antimicrobial drugs, has a strong penetration, high blood concentration, low toxicity, not easy to produce drug resistance, and can be quickly distributed to other organs.
    • This drug is easy to absorb orally, intramuscular injection is more effective. New quinolone broad-spectrum antimicrobial drug with very strong effect on Gram-positive and negative bacteria.
    Our advantage
    Our Factory
    Shipping
    Tel: 86-29-89601602
    WhatsApp: 8615091775531
    WeChat: 15091775531
    E-mail: sales21@interlgroup.com
    Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
    ©2023 Xi'an Henrikang Biotech Co., Ltd.,